Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
Open | $1.24 |
Close | $1.25 |
Volume / Avg. | 25.22K / 33.23K |
Day Range | $1.21 - $1.28 |
52 Wk Range | 1.01 - 5.41 |
Market Cap | $11.33M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.24% |
Days to Cover | 1.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN), Addex Therapeutics (NASDAQ:ADXN), Can Fite Biofarma (AMEX:CANF) and Sensei Biotherapeutics (NASDAQ:SNSE).
Alterity Therapeutics has a consensus price target of $5.67.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $1.255 last updated September 24, 2024 at 2:50 PM EDT.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics’s Q2 earnings are confirmed for Tuesday, October 8, 2024.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.